Clark Capital Management Group’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-24,927
| Closed | -$2.32M | – | 337 |
|
|
2021
Q1 | $2.32M | Sell |
24,927
-137,059
| -85% | -$12.7M | 0.04% | 215 |
|
|
2020
Q4 | $14.5M | Sell |
161,986
-42,157
| -21% | -$3.78M | 0.24% | 152 |
|
|
2020
Q3 | $21.1M | Buy |
204,143
+166,978
| +449% | +$17.3M | 0.4% | 106 |
|
|
2020
Q2 | $2.94M | Buy |
+37,165
| New | +$2.94M | 0.06% | 176 |
|
|
2018
Q2 | – | Sell |
-44,826
| Closed | -$2.36M | – | 277 |
|
|
2018
Q1 | $2.36M | Sell |
44,826
-32,419
| -42% | -$1.71M | 0.07% | 155 |
|
|
2017
Q4 | $3.59M | Buy |
77,245
+22,103
| +40% | +$1.03M | 0.11% | 127 |
|
|
2017
Q3 | $2.23M | Buy |
55,142
+2,129
| +4% | +$86.1K | 0.08% | 156 |
|
|
2017
Q2 | $1.8M | Buy |
+53,013
| New | +$1.8M | 0.07% | 166 |
|